Clinical Trial Update: Resveratrol for the Prevention of Bone Loss in Postmenopausal Women [NA]

View source ↗

Summary

A completed clinical trial evaluating resveratrol for prevention of bone loss in postmenopausal women with low bone mass.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteopenia
• Osteoporosis
• Postmenopausal Osteoporosis

Drugs mentioned

• Resveratrol (resveratrol)

Snippet

Sponsor: University of Delaware | Conditions: Low Bone Mass | NA | Status: COMPLETED